3. Owczarek-Lipska M, Mulahasanovic L, Obermaier CD, Hortnagel K, Neubauer BA, Korenke GC,
et al. Novel mutations in the
GJC2 gene associated with Pelizaeus-Merzbacher-like disease. Mol Biol Rep 2019;46:4507–4516.
4. Uhlenberg B, Schuelke M, Ruschendorf F, Ruf N, Kaindl AM, Henneke M,
et al. Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease. Am J Hum Genet 2004;75:251–260.
5. Biancheri R, Rosano C, Denegri L, Lamantea E, Pinto F, Lanza F,
et al. Expanded spectrum of Pelizaeus-Merzbacher-like disease: literature revision and description of a novel
GJC2 mutation in an unusually severe form. Eur J Hum Genet 2013;21:34–39.
14. Philippot C, Griemsmann S, Jabs R, Seifert G, Kettenmann H, Steinhauser C. Astrocytes and oligodendrocytes in the thalamus jointly maintain synaptic activity by supplying metabolites. Cell Rep 2021;34:108642.
16. Chen N, Wang J, Jiang Y, Wu Y, Hao H, Ji T. Different mutations of gap junction connexin 47 lead to discrepant activation of unfolded protein response pathway in Pelizaeus-Merzbacher-like disease. Neuropediatrics 2017;48:426–431.
17. Orthmann-Murphy JL, Salsano E, Abrams CK, Bizzi A, Uziel G, Freidin MM,
et al. Hereditary spastic paraplegia is a novel phenotype for
GJA12/GJC2 mutations. Brain 2009;132:426–438.
18. Orthmann-Murphy JL, Enriquez AD, Abrams CK, Scherer SS. Loss-of-function
GJA12/Connexin47 mutations cause Pelizaeus-Merzbacher-like disease. Mol Cell Neurosci 2007;34:629–641.
19. Zlomuzica A, Tress O, Binder S, Rovira C, Willecke K, Dere E. Changes in object recognition and anxiety-like behaviour in mice expressing a
Cx47 mutation that causes Pelizaeus-Merzbacher-like disease. Dev Neurosci 2012;34:277–287.